{"database": "openregs", "table": "documents", "rows": [["FDA-2003-N-0097-0032", "FDA", "FDA-2003-N-0097", "Attachment 2 Farrugia and Prowse Studies on the procurement of blood coagulation factor VIII: effects of plasma freezing rate and storage conditions on cryoprecipitate quality. J Clin Pathol 1985; 38:433-437 re: Comment from \nEuropean Pharmacopoeia (PhEur)", "Supporting & Related Material", "Background Material", "2015-12-08T05:00:00Z", 2015, 12, null, null, "2025-03-25T15:44:33Z", null, 0, 0, "0900006480483a63"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2003-N-0097-0032"], "units": {}, "query_ms": 9.37059591524303, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}